Serum activities of dipeptidyl-aminopeptidase II and dipeptidyl-aminopeptidase IV in tumor-bearing animals and in cancer patients.

[1]  J. Mcdonald,et al.  Dipeptidyl arylamidase II of the pituitary. Properties of lysylalanyl-beta-naphthylamide hydrolysis: inhibition by cations, distribution in tissues, and subcellular localization. , 1968, The Journal of biological chemistry.

[2]  S. Okuyama,et al.  Glycylprolyl beta-naphthylamidase activities in serum, liver and kidney of rats in chronic carbon tetrachloride intoxication. , 1976, Clinica chimica acta; international journal of clinical chemistry.

[3]  T. Nagatsu,et al.  Serum glycylproline p-nitroanilidase activity in blood cancers. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[4]  T. Nagatsu,et al.  X-Prolyl dipeptidyl-aminopeptidase activity, with X-proline p-nitroanilides as substrates, in normal and pathological human sera. , 1976, Clinical chemistry.

[5]  T. Nagatsu,et al.  A sensitive and specific assay for dipeptidyl-aminopeptidase II in serum and tissues by liquid chromatography-fluorometry. , 1985, Analytical Biochemistry.

[6]  T. Vanha-Perttula,et al.  Comparison of dipeptide arylamidase I and II. Amino acid arylamidase and acid phosphatase activities in normal and pathological human sera. , 1973, Clinica chimica acta; international journal of clinical chemistry.

[7]  S. Kakumu,et al.  glycylprolyl β-naphthylamidase activity in human serum , 1975 .

[8]  T. Kato,et al.  Fluorescence assay of x-prolyl dipeptidyl-aminopeptidase activity with a new fluorogenic substrate. , 1978, Biochemical medicine.